Home
Bergen Gynecologic Cancer Research Group
  1. Alonso-Alconada, L., M. Santacana, P. Garcia-Sanz, L. Muinelo-Romay, E. Colas, C. Mirantes, M. Monge, J. Cueva, E. Oliva, R. A. Soslow, M. A. Lopez, J. Palacios, J. Prat, J. Valls, C. Krakstad, H. Salvesen, A. Gil-Moreno, R. Lopez-Lopez, X. Dolcet, G. Moreno-Bueno, J. Reventos, X. Matias-Guiu and M. Abal (2015). "Annexin-A2 as predictor biomarker of recurrent disease in endometrial cancer." Int J Cancer 136(8): 1863-1873.

 

  1. Bartlett, T. E., A. Jones, E. L. Goode, B. L. Fridley, J. M. Cunningham, E. M. Berns, E. Wik, H. B. Salvesen, B. Davidson, C. G. Trope, S. Lambrechts, I. Vergote and M. Widschwendter (2015). "Intra-Gene DNA Methylation Variability Is a Clinically Independent Prognostic Marker in Women's Cancers." PLoS One 10(12): e0143178.

 

  1. Berg, A., E. A. Hoivik, S. Mjos, F. Holst, H. M. Werner, I. L. Tangen, A. Taylor-Weiner, W. J. Gibson, K. Kusonmano, E. Wik, J. Trovik, M. K. Halle, A. M. Oyan, K. H. Kalland, A. D. Cherniack, R. Beroukhim, I. Stefansson, G. B. Mills, C. Krakstad and H. B. Salvesen (2015). "Molecular profiling of endometrial carcinoma precursor, primary and metastatic lesions suggests different targets for treatment in obese compared to non-obese patients." Oncotarget 6(2): 1327-1339.

 

  1. Bredholt, G., M. Mannelqvist, I. M. Stefansson, E. Birkeland, T. H. Bo, A. M. Oyan, J. Trovik, K. H. Kalland, I. Jonassen, H. B. Salvesen, E. Wik and L. A. Akslen (2015). "Tumor necrosis is an important hallmark of aggressive endometrial cancer and associates with hypoxia, angiogenesis and inflammation responses." Oncotarget 6(37): 39676-39691.

 

 

  1. Edqvist, P. H., J. Huvila, B. Forsstrom, L. Talve, O. Carpen, H. B. Salvesen, C. Krakstad, S. Grenman, H. Johannesson, O. Ljungqvist, M. Uhlen, F. Ponten and A. Auranen (2015). "Loss of ASRGL1 expression is an independent biomarker for disease-specific survival in endometrioid endometrial carcinoma." Gynecol Oncol 137(3): 529-537.

 

 

  1. Haldorsen, I. S., M. Popa, T. Fonnes, N. Brekke, R. Kopperud, N. C. Visser, C. B. Rygh, T. Pavlin, H. B. Salvesen, E. McCormack and C. Krakstad (2015). "Multimodal Imaging of Orthotopic Mouse Model of Endometrial Carcinoma." PLoS One 10(8): e0135220.

 

  1. Haslene-Hox, H., E. Oveland, K. Woie, H. B. Salvesen, O. Tenstad and H. Wiig (2015). "Distribution volumes of macromolecules in human ovarian and endometrial cancers--effects of extracellular matrix structure." Am J Physiol Heart Circ Physiol 308(1): H18-28.

 

  1. Husby, J. A., B. C. Reitan, M. Biermann, J. Trovik, L. Bjorge, I. J. Magnussen, O. O. Salvesen, H. B. Salvesen and I. S. Haldorsen (2015). "Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients." J Nucl Med 56(8): 1191-1198.

 

  1. Husby, J. A., O. O. Salvesen, I. J. Magnussen, J. Trovik, L. Bjorge, H. B. Salvesen and I. S. Haldorsen (2015). "Tumour apparent diffusion coefficient is associated with depth of myometrial invasion and is negatively correlated to tumour volume in endometrial carcinomas." Clin Radiol 70(5): 487-494.

 

 

  1. Krakstad, C., I. L. Tangen, E. A. Hoivik, M. K. Halle, A. Berg, H. M. Werner, M. B. Raeder, K. Kusonmano, J. X. Zou, A. M. Oyan, I. Stefansson, J. Trovik, K. H. Kalland, H. W. Chen and H. B. Salvesen (2015). "ATAD2 overexpression links to enrichment of B-MYB-translational signatures and development of aggressive endometrial carcinoma." Oncotarget 6(29): 28440-28452.

 

  1. Solheim, O., C. G. Trope, E. Rokkones, J. Kaern, T. Paulsen, H. B. Salvesen, B. Hagen, A. B. Vereide and S. D. Fossa (2015). "Fertility and gonadal function after adjuvant therapy in women diagnosed with a malignant ovarian germ cell tumor (MOGCT) during the "cisplatin era"." Gynecol Oncol 136(2): 224-229.

 

  1. Stefansson, I. M., M. Raeder, E. Wik, M. Mannelqvist, K. Kusonmano, G. Knutsvik, I. Haldorsen, J. Trovik, A. M. Oyan, K. H. Kalland, A. C. Staff, H. B. Salvesen and L. A. Akslen (2015). "Increased angiogenesis is associated with a 32-gene expression signature and 6p21 amplification in aggressive endometrial cancer." Oncotarget 6(12): 10634-10645.

 

  1. Teschendorff, A. E., S. H. Lee, A. Jones, H. Fiegl, M. Kalwa, W. Wagner, K. Chindera, I. Evans, L. Dubeau, A. Orjalo, H. M. Horlings, L. Niederreiter, A. Kaser, W. Yang, E. L. Goode, B. L. Fridley, R. G. Jenner, E. M. Berns, E. Wik, H. B. Salvesen, G. B. Wisman, A. G. van der Zee, B. Davidson, C. G. Trope, S. Lambrechts, I. Vergote, H. Calvert, I. J. Jacobs and M. Widschwendter (2015). "HOTAIR and its surrogate DNA methylation signature indicate carboplatin resistance in ovarian cancer." Genome Med 7: 108.

 

  1. Teschendorff, A. E., Z. Yang, A. Wong, C. P. Pipinikas, Y. Jiao, A. Jones, S. Anjum, R. Hardy, H. B. Salvesen, C. Thirlwell, S. M. Janes, D. Kuh and M. Widschwendter (2015). "Correlation of Smoking-Associated DNA Methylation Changes in Buccal Cells With DNA Methylation Changes in Epithelial Cancer." JAMA Oncol 1(4): 476-485.

 

  1. Westin, S. N., Z. Ju, R. R. Broaddus, C. Krakstad, J. Li, N. Pal, K. H. Lu, R. L. Coleman, B. T. Hennessy, S. J. Klempner, H. M. Werner, H. B. Salvesen, L. C. Cantley, G. B. Mills and A. P. Myers (2015). "PTEN loss is a context-dependent outcome determinant in obese and non-obese endometrioid endometrial cancer patients." Mol Oncol 9(8): 1694-1703.

 

  1. Ytre-Hauge, S., J. A. Husby, I. J. Magnussen, H. M. Werner, O. O. Salvesen, L. Bjorge, J. Trovik, I. M. Stefansson, H. B. Salvesen and I. S. Haldorsen (2015). "Preoperative tumor size at MRI predicts deep myometrial invasion, lymph node metastases, and patient outcome in endometrial carcinomas." Int J Gynecol Cancer 25(3): 459-466